| Filed On | Filing |
|---|---|
| 16 Nov 2026 | SCHEDULE 13G/A |
| 16 Nov 2026 | SCHEDULE 13G/A |
| 12 Nov 2026 | 10-Q |
| 12 Nov 2026 |
8-K: Results of Operations and Financial Condition
PALO ALTO, Calif., November 12, 2026 -- Kodiak Sciences Inc. (Nasdaq: KOD), today reported recent business highlights and financial results for the third quarter ended September 30, 2026. |
| 06 Nov 2026 |
Form 4: Baker Bros. Advisors Lp, Director and 5 others
Bought 160,658 shares ($15.8M) · Bought 86,432 shares ($8.51M) |
| 26 Oct 2026 |
Form 4: Yang Taiyin, Director
Received 20,000 shares by exercise or conversion ($47K) |
| 23 Oct 2026 |
Form 4: Borgeson John A., Chief Financial Officer
Received 30,000 shares by exercise or conversion ($74.7K) · Sold 30,000 shares ($2.7M) |
| 21 Oct 2026 | 144 |
| 20 Oct 2026 | S-3ASR |
| 30 Sep 2026 | SCHEDULE 13D/A |
| 30 Sep 2026 |
Form 4: Baker Bros. Advisors Lp, Director and 5 others
Bought 681,866 shares ($60.5M) · Bought 33,726 shares ($2.87M) |
| 30 Sep 2026 |
Form 4: Baker Bros. Advisors Lp, Director and 5 others
Bought 418,323 shares ($35M) |
| 30 Sep 2026 |
Form 4: Baker Bros. Advisors Lp, Director and 5 others
Bought 807,840 shares ($58.6M) |
| 29 Sep 2026 |
Form 4: Perlroth Victor, Director
Received 1,280,524 shares by exercise or conversion ($5.38M) |
| 28 Sep 2026 |
8-K: Other Events
Zenkuda and tabirafusp-ted Meet Primary Endpoints in Pivotal DAYBREAK Trial in wAMD, with Zenkuda Demonstrating a Potential New Standard-of-Care Profile with Strong Immediacy and Sustained Clinical Effect with Majority of Patients on 24-... |
| 14 Aug 2026 | SCHEDULE 13G |
| 13 Aug 2026 | 10-Q |
| 13 Aug 2026 |
8-K: Results of Operations and Financial Condition
PALO ALTO, Calif., August 13, 2026 -- Kodiak Sciences Inc. (Nasdaq: KOD), today reported recent business highlights and financial results for the second quarter ended June 30, 2026. |
| 17 Jul 2026 |
Form 4: Borgeson John A., Chief Financial Officer
Granted 66,500 Stock Option (Right to Buy) |
| 17 Jul 2026 |
Form 4: Perlroth Victor, Director
Granted 100,000 Stock Option (Right to Buy) |
Loading...